by Nada Hassanein, USA Today Credit: Pixabay/CC0 Public Domain The Food and Drug Administration has approved Sunlenca, an injectable therapy to suppress HIV for patients who suffered drug resistance to other regimens. Experts say the new injectable, which works with less frequent dosing, can be a game changer for those whose infections don’t respond to...
